Andy Pettitte testifies that Clemens spoke of his drug use


UPDATE:  Well, it was nice while it lasted, but Pettitte’s testimony just became pretty useless.

9:12 AM: There were no surprises in Andy Pettitte’s testimony at the Roger Clemens trial yesterday. Now it’s just a matter of whether the jury believes the 1999 Roger Clemens or the 2005 Roger Clemens to whom Pettitte spoke:

Without emotion, as if he were facing a particularly tough batter, Pettitte said that Clemens admitted to him in 1999 or 2000 that he had used human growth hormone, which is now banned by baseball.

“Roger had mentioned to me that he had taken H.G.H. and that it could help with recovery,” Pettitte said. “You know, that’s all I really remember about the conversation.”

And, Pettitte said without flinching, that Clemens accused him in 2005 of remembering that conversation inaccurately. Clemens said it was his wife, not him, who had used H.G.H.

“Obviously, I was a little flustered because I thought that he had told me he did,” Pettitte said. “My reaction after that was, well, no good asking him or talking to him about this now, and I just walked out, end of the conversation.” …

That’s basically the crux of it all. That and a little bit of Pettitte’s own history with HGH and whether the jury will assume that, due to their closeness and the company they kept, they were both doing the same stuff.

It’s easy to convince yourself, based on what we all know what was going on in 2005, that Clemens changed his story to Pettitte because he was aware — based on the famous Rafael Palmiero/Mark McGwire hearings — that others would be called on to talk about drug use and he wanted to start laying the groundwork for denials.  It’s just as easy to say “man, how dumb would Clemens be to change his story in 2005 when, if he was really using, others would be in a position to say so.” Now, I think Clemens is dumb, actually, but the jury isn’t gonna get to hear about a lot of that stuff, so it may not matter here.

Which is another way to say that it’s hard to say what the jury will take away from Pettitte’s testimony.  And makes me continue to believe that the only thing that matters in this case is what Brian McNamee says, how he says it and what the jury thinks of it.

2018 Preview: Tampa Bay Rays

Getty Images
Leave a comment

Between now and Opening Day, HardballTalk will take a look at each of baseball’s 30 teams, asking the key questions, the not-so-key questions, and generally breaking down their chances for the 2018 season. Next up: The Tampa Bay Rays.

A lot of teams start one season looking very different than they did at the end of the previous season. Usually you can see those changes coming as early as August or September. What the Rays look like now, on the eve of the 2018 regular season, however, is very different than the sort of change we assumed as recently as the Winter Meetings.

We knew they’d let Alex Cobb walk in free agency and they did. But we did not expect them to trade Evan Longoria, to designate Corey Dickerson for assignment coming off an All-Star year, to trade 30-homer outfielder Steven Souza, or to trade Jake Odorizzi as spring training was getting underway as opposed to some time later when, perhaps, he could bring more value. The baseball justifications for some of these trades were better than they were for others, but the way they were done and the timing of it all cast a pall on the offseason, appearing as they did to be payroll slashing moves. The certainly didn’t impress the MLBPA, which filed a grievance against Tampa Bay last month, accusing them of pocketing revenue sharing money instead of trying to make the team better.

None of that played well, but if you take a couple of steps back, it’s possible to defend it all by realizing that even with all of those guys, the Rays were an 80-win team last year and would not have had a huge amount of upside this year if they had kept it all together. I’ll leave it to prospect experts, number crunchers to decide whether the Rays did a good job of tearing it down — and I think they could’ve done better than they did with stopgap measures until their minor league talent matures — but it’s at least understandable that they wanted to tear it down and start anew.

Until the fruits of those deals — and the fruits of a minor league system which has been pretty darn good in recent years — are ripe, though, the big league Rays are going to have a lot of question marks.

On offense the biggest question mark is health and durability. Here’s a pretty plausible Opening Day lineup Kevin Cash may send out there:

DH Denard Span
3B Matt Duffy
CF Kevin Kiermaier
RF Carlos Gomez
2B Brad Miller
C Wilson Ramos
1B C.J. Cron
SS Adeiny Hechavarria
LF Mallex Smith

Not terrible, but not durable or, in some cases, consistent. Kiermaier has had some freak injuries, but the nature of his play — hard, fast and diving for stuff — makes that a hazard and, as such, he’s really only played in one full season. Matt Duffy missed all of last year and, let’s face it, has never struck fear into the hearts of opposing pitchers. Wilson Ramos knows the disabled list like few others. Meanwhile, Carlos Gomez, C.J. Cron and Brad Miller have had fairly substantial swings in production across recent and within recent seasons. Adeiny Hechavarria and Mallex Smith are not serious offensive threats.

It’s easy to squint and to imagine Span, Kiermaier, Ramos, Gomez and maybe Cron forming the nucleus of a respectable attack, but it’s also easy to see half of that lineup playing in only, like, 107 games, Cash penciling in dudes like Jesus Sucre and Daniel Robertson a lot or putting Denard Span out in the outfield more than he should to cover for whoever. The Rays featured the 14th-best offense in the AL in 2017. I can see a case for it improving a tad, but not by much, and if the injury fairy flies through the window, this could be really bad.

On the upside, most of these guys can pick it pretty well, so the defense should be pretty decent and potentially even superior. The pitching is good on paper too, but there is gonna be some weirdness afoot if Cash sticks with the plan he outlined earlier this month.

Even with the departure of Cobb and Odorizzi — and even with the season-ending surgery to top prospect Brent Honeywell — the Rays have five good starters in Chris Archer, Nate Eovaldi, Blake Snell, Jake Faria and Matt Andriese. Except they’re not going to use all five starters in their rotation. They’re going to go with a four-man rotation and a bullpen game every fifth day. At present it appears that Andriese, who started 17 games last year, is the odd man out and will be part of the all-hands-on-deck crew on day 5, whenever that comes up.

Early on this should not make a difference. There are a lot of off days in the first month of the season, so the need for that bullpen day will be pretty limited. One wonders, though, what this will do to their effectiveness and durability as the temperature rises and the season wears on. Yes, “bullpenning” got a lot of press in the postseason, but the idea that a bullpen can stay fresh with such a high-level of use for 5-6 months with few days off is a questionable one. That’s especially the case when three of the Rays’ four starters — Eovaldi, Faria and Snell — pitched limited innings last year and can’t be expected to go six or seven innings per start in 2018 (who can anymore?). Maybe Archer is a horse, but the rest of your games you’re going to need three relievers to finish things up based on how life works these days. Maybe more.

In light of that, is the bullpen going to be able to handle nine innings once every five days? Color me dubious. I think they’ll be fried by July. At least if they truly do use that fifth day as a true bullpen day and don’t, say, just call up a new fifth starter every week and a half and use that slot to audition organizational depth before ultimately just handing it over to Andriese. Indeed, now that I’m thinking about it, I’d wager that the fifth day plan morphs into that pretty quickly and that we’ll be smiling at the notion of a true bullpen day by the All-Star break.

As for the arms in that bullpen, Alex Colome is the closer, mostly because the Rays couldn’t find anyone to deal him to this past offseason. In support are old hands Daniel Hudson and Sergio Romo, neither of whom have been relief aces in recent years, even if Romo did do well for the Rays after coming over late last season. Dan Jennings, Jose Alvarado, Ryne Stanek and a cast of similarly anonymous guys will take the ball a lot. Even Johnny Venters, who had three Tommy John surgeries, could be in the mix at some point. The cast will be as big as “Love Actually.” Whether they are as annoying depends on who you’re rooting for.

Where does that leave the Rays? It leaves them with some serious dice rolling in the lineup, some good defense, some respectable pitching but a potentially odd and possibly detrimental approach to its deployment. It leaves them with a still very good farm system and a roster that looks really nice for 2020. I think it leaves them in some pretty serious trouble for 2018, though, especially in a division as top heavy as the AL East.

As far as on-the-fly rebuilds go, it’s not a bad one, but it’s still one that’s gonna leave the Rays in the low-80s win-wise at best, with some pretty serious potential downside.

Prediction: Fourth Place, AL East.